SCHEMBL24258032

SCHEMBL24258032

C=C[S+]([O-])Nc1ccc(-c2noc(Cc3ccc(Cl)c(Cl)c3)n2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 1/20 0.42
ERCC4 Q92889 1/20 0.42
TSHR P16473 6/20 0.41
MAPK1 P28482 5/20 0.41
TDP1 Q9NUW8 4/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 4/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
MEN1 O00255 3/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 4/20 0.38
ALOX15 P16050 1/20 0.38
RAB9A P51151 2/20 0.37
ALDH1A1 P00352 2/20 0.36
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258089 0.82 ERCC1 (0.45) ERCC1ERCC4TSHRMAPK1TDP1
SCHEMBL24258031 0.82 ERCC1 (0.41) ERCC1ERCC4TSHRMAPK1TDP1
SCHEMBL24258075 0.79 ERCC1 (0.52) ERCC1ERCC4TSHRMAPK1TDP1
SCHEMBL24258081 0.77 ERCC1 (0.45) ERCC1ERCC4TSHRMAPK1TDP1
SCHEMBL24258080 0.77 ERCC1 (0.56) ERCC1ERCC4TSHRMAPK1TDP1
SCHEMBL26004923 0.77 L3MBTL1 (0.50) ERCC1ERCC4TSHRMAPK1TDP1
SCHEMBL24258029 0.77 ERCC1 (0.50) ERCC1ERCC4TSHRMAPK1TDP1
SCHEMBL26004989 0.77 ERCC1 (0.44) ERCC1ERCC4TSHRMAPK1TDP1
SCHEMBL26004922 0.74 ABL1 (0.44) ERCC1ERCC4TSHRMAPK1TDP1
SCHEMBL24258035 0.74 ERCC1 (0.47) ERCC1ERCC4TSHRMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035805-A1 SUBSTITUTED 1,2,4-OXADIAZOLES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed